Back

siRNA in atherosclerotic cardiovascular disease: 5+ years from promise to real-world practice and the next chapter

28 August 2026 (12:57 - 13:09)
Organised by: Logo
Congress Presentation Part of: Redefining low-density lipoprotein cholesterol management: a practical approach to early and sustained goal attainment Lipid-Lowering Agents Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ingo Hilgendorf

Charité - University Medicine Berlin, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor K. Ray (London, GB)
Presentation thumbnail
State-of-the-art lipid control in atherosclerotic cardiovascular disease - progress or plateau?
Professor K. Ray (London, GB)
Presentation thumbnail
Closing the implementation gap: strategies for therapeutic escalation and adherence in low-density lipoprotein cholesterol management
Ms J. Schubert (Uppsala, SE)
Presentation thumbnail
Cracking the code in lipid-lowering therapy implementation — a practical exchange followed by Q&A and close

Access the full session

Session thumbnail
Redefining low-density lipoprotein cholesterol management: a practical approach to early and sustained goal attainment

The Event

Event poster

ESC Congress 2026

28 August 2026 12:57 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
15 April 2024
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
29 August 2025
thumbnail
Congress Presentation
What’s new on lipid-lowering drugs: from statins to gene editing and beyond
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources